Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novo Nordisk Sales Rep Loses Retaliation Lawsuit
Pharmalot
Tuesday, August 10, 2010 - 9:52am
tags:
Novo Nordisk, drug reps, sexual harassment
Elan puts sale of drug delivery unit on hold
Reuters
Tuesday, August 10, 2010 - 9:51am
tags:
Elan, M&A, drug delivery
China May Spend $1.5 Billion to Support of Drug Industry, 21st Herald Say
Bloomberg
Tuesday, August 10, 2010 - 9:23am
tags:
China, development
Are You a Great Investment, Sequenom?
Motley Fool
Tuesday, August 10, 2010 - 9:21am
tags:
Sequenom
Bristol-Myers’ Uniquely Awful Sexual Harassment Policy: Silence Is Consent
BNET Pharma
Tuesday, August 10, 2010 - 9:12am
tags:
Bristol-Myers Squibb, sexual harassment
SciClone 2Q profit falls as sales skid, costs rise
Yahoo/AP
Tuesday, August 10, 2010 - 9:05am
tags:
SciClone, earnings
Teva completes buyout of German drugmaker
Yahoo/AP
Tuesday, August 10, 2010 - 7:36am
tags:
Teva Pharmaceuticals, Europe, Ratiopharm, M&A
Qiagen Hopes to Double China Revenues in 2010
Seeking Alpha
Tuesday, August 10, 2010 - 7:35am
tags:
China, Qiagen
Vertex: At the Finish Line for a Hepatitis C Cure
Seeking Alpha
Tuesday, August 10, 2010 - 7:33am
tags:
Vertex Pharmaceuticals, hepatitis C, Merck, Telaprevir, Boceprevir
Dendreon's in Trouble
Motley Fool
Monday, August 9, 2010 - 8:16pm
tags:
Provenge, FDA, prostate cancer, Dendreon
Endo Pharmaceuticals to buy Penwest for $144M
Bizjournals.com
Monday, August 9, 2010 - 5:52pm
tags:
Endo, Penwest, M&A
Thumbs Up for Valeant's Potiga Means Victory for Biovail
Minyanville
Monday, August 9, 2010 - 5:51pm
tags:
Valeant Pharmaceuticals, Biovail, Potiga, GSK, epilepsy
Kaleetan Seeks to Stand on Dendreon's Shoulders
Motley Fool
Monday, August 9, 2010 - 2:27pm
tags:
Kaleetan, Dendreon
What is Genzyme CEO's 'magic' number?
Fierce Biotech
Monday, August 9, 2010 - 2:26pm
tags:
Genzyme, Pharma CEOs, M&A, Sanofi, Henri Termeer
Repros drug gets positive FDA feedback
Bizjournals.com
Monday, August 9, 2010 - 2:18pm
tags:
Androxal, FDA, Repros Therapeutics
3 Stocks to Play Biotech
Motley Fool
Monday, August 9, 2010 - 2:17pm
tags:
Dendreon, ONYX Pharmaceuticals, Geron, Isis Pharmaceuticals, InterMune
Are Amgen Sales Reps Looking At Your Medical Records?
BNET Pharma
Monday, August 9, 2010 - 2:15pm
tags:
Amgen, medical records, lawsuits, drug reps
Drugmaker Merck discloses Justice, SEC probes of possible foreign anti-bribery law violations
Yahoo/AP
Monday, August 9, 2010 - 1:36pm
tags:
Merck, SEC, bribery, DOJ
GTx loss widens in second quarter
Bizjournals.com
Monday, August 9, 2010 - 11:12am
tags:
GTx, earnings
FDA advisors to weigh Meridia's safety
Fierce Pharma
Monday, August 9, 2010 - 11:07am
tags:
FDA, Meridia, obesity, Abbott Laboratories

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.